Motor neuron disease: A paraneoplastic process associated with anti-Hu antibody and small-cell lung carcinoma

Annals of Neurology

Volumn 40, Issue 1, 1996, Pages 112-116

  Verma, Ashok ^a   Berger, Joseph R ^b   Snodgrass, Susan ^c   Petito, Carol ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ANTIBODY; CANCER ANTIBODY; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IMMUNOGLOBULIN; PREDNISONE; VINCRISTINE;

ADULT; ANTERIOR HORN CELL; ANTIBODY TITER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MALE; MOTOR NEURON DISEASE; MUSCLE BIOPSY; MUSCLE DENERVATION; MUSCLE WEAKNESS; PARANEOPLASTIC SYNDROME; PLASMAPHERESIS; PRIORITY JOURNAL; PURKINJE CELL; TREATMENT FAILURE;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; CARCINOMA, SMALL CELL; CEREBELLUM; FATAL OUTCOME; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; NISSL BODIES; PREDNISONE; PURKINJE CELLS;

EID: 0029890881     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400118     Document Type: Article

References (29)

1. Wechsler IS, Sapirstein MR, Stein A. Primary and symptomatic amyotrophic lateral sclerosis: a clinical study of 81 cases. Am J Med Sci 1944;208:70-81
2. Brain WR, Henson RA. Neurological syndromes associated with carcinoma. Lancet 1958;2:271-275
3. Brain WR. The neurological complications of neoplasms. Lancet 1963;1:179-184
4. Norris FH Jr, Engel WK. Carcinomatous amyotrophic lateral sclerosis. In: Brain L, Norris F Jr, eds. The remote effects of cancer on the nervous system. New York: Grune & Stratton, 1964:24-34
5. Brain WR, Croft PB, Wilkinson M. Motor neurone disease, a manifestation of neoplasm (with a note on the course of classical motor neurone disease). Brain 1965;88:479-500
6. Urich H. The pathology of carcinomatous neurological syndromes. In: Whittey CWM, Hughes JT, MacCallum FO, eds. Virus diseases and the nervous system. Oxford: Blackwell Scientific, 1969:223-229
7. Henson RA, Ulrich H. Miscellaneous and possibly fortuitous associations. In: Cancer and the nervous system. Oxford: Blackwell Scientific, 1982:432-451
8. Norris FH Jr. Remote effects of cancer on the spinal cord. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology, vol 38. Amsterdam: North Holland, 1979:669-677
9. Shy GM, Silverstein I. A study of the effects upon the motor unit by remote malignancy. Brain 1965:88:515-528
10. Erlington GM, Murray NMF, Spiro SG, Newsom-Davis J. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry 1991;54:764-767
11. O'Neill JH, Murray NMF, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome: a review of 50 cases. Brain 1988; 111:577-596
12. Graus F, Elkon KB, Cordon-Cardo C, Posner JB. Sensory neuronopathy and small cell lung cancer: anti-neuronal antibody that also reacts with the tumor. Am J Med 1986;80:45-52
13. Hawley RJ, Cohen MH, Saini N, Armbrustmacher VW. The carcinomatous neuromyopathy of oat cell cancer. Ann Neural 1980;7:65-72
14. Babikian VL, Stefansson K, Dieperink ME, et al. Paraneoplastic myelopathy: antibodies against protein in normal spinal cord and underlying neoplasm. Lancet 1985;2:49-50
15. Greenlee JE, Lipton HL. Anticerebellar antibodies in serum and CSF of a patient with oat cell carcinoma of lung and paraneoplastic cerebellar degeneration. Ann Neurol 1986;19: 82-85
16. Brennan LV, Craddock PR. Limbic encephalopathy as a nonmetastatic complication of oat cell cancer. Am J Med 1983; 75:518-520
17. Ridley A, Kennard C, Scholtz CL, et al. Omnipause neurons in two cases of opsoclonus associated with oat cell carcinoma of the lung. Brain 1987;110:1699-1709
18. Kornguth SE, Kalinke T, Scjutta H, Dahl D. Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res 1986;46:2588-2595
19. Dayan AD, Croft PB, Wilkinson M. Association of carcinomatous neuromyopathy with different histological types of carcinoma of the lung. Brain 1965;88:435-438
20. Anderson NE, Rosenblum MK, Graus F, et al. Autoantibodies in paraneoplastic syndromes associated with small cell lung cancer. Neurology 1988;38:1391-1398
21. Dropcho EJ, Stanton C, Oh SJ. Neuronal antinuclear antibodies in a patient with Lambert-Eaton myasthenic syndrome and small cell lung carcinoma. Neurology 1989;39:249-251
22. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients. Medicine (Baltimore) 1992;71: 59-72
23. Dalmau J, Furneaux HM, Gralla RJ, et al. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer - a quantitative Western blot analysis. Ann Neurol 1990;27:544-552
24. Dalmau J, Posner JB. Neurologic paraneoplistic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurology 1994;44:2241-2246
25. Lennon VA. Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature. Neurology 1994;44:2236-2240
26. Furneaux HF, Reich L, Posner JB. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 1990;40:1085-1091
27. Batson OA, Fantle DM, Stewart JA. Paraneoplastic encephalomyelitis: dramatic response to chemotherapy alone. Cancer 1992;69:1291-1293
28. Stark E, Wurster U, Patzold U, et al. Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration. Arch Neurol 1995;52:814-818
29. Graus F, Bega F, Delattre JY, et al. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 1992;42:536-540